NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Patients with osteoporosis at higher fracture risk
Date of first enrollment	22/12/2016
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : MN-10-T AI INN of investigational material : Teriparatide Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigational material : Injection control material(s) Generic name etc : MN-10-T INN of investigational material : Teriparatide Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigational material : Injection

Outcome(s)

Primary Outcome	Percent change in lumbar spine bone mineral density
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 65age old
Age maximum	Not applicable
Gender	Both
Include criteria	Patients with osteoporosis at higher fracture risk
Exclude criteria